We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$96.8B
AUM Growth
-$1.63B
Cap. Flow
-$6.28B
Cap. Flow %
-6.49%
Top 10 Hldgs %
7.41%
Holding
4,043
New
538
Increased
1,352
Reduced
1,501
Closed
517

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$735M
2
AAPL icon
Apple
AAPL
+$542M
3
MA icon
Mastercard
MA
+$523M
4
CRM icon
Salesforce
CRM
+$484M
5
PEP icon
PepsiCo
PEP
+$402M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 10.4%
3 Financials 10.22%
4 Healthcare 8.57%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPXS icon
3926
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
-96
Closed -$4.52K
SPXU icon
3927
ProShares UltraPro Short S&P 500
SPXU
$436M
-156
Closed -$10.5K
SQQQ icon
3928
ProShares UltraPro Short QQQ
SQQQ
$2.21B
-2,194
Closed -$215K
SRPT icon
3929
CALL
Sarepta Therapeutics
SRPT
$1.66B
-1,800
Closed -$30.8K
SRPT icon
3930
Sarepta Therapeutics
SRPT
$1.66B
-1,598,472
Closed -$27.3M
SRPT icon
3931
PUT
Sarepta Therapeutics
SRPT
$1.66B
-100
Closed -$1.71K
SSBK
3932
DELISTED
Southern States Bancshares
SSBK
-9,934
Closed -$361K
SSRM icon
3933
SSR Mining
SSRM
$5.57B
-409,093
Closed -$5.21M
STGW icon
3934
Stagwell
STGW
$1.84B
-54,312
Closed -$244K
STIM icon
3935
Neuronetics
STIM
$120M
-24,914
Closed -$87K
STR
3936
DELISTED
Sitio Royalties
STR
-906,098
Closed -$16.7M
SWTX
3937
DELISTED
SpringWorks Therapeutics
SWTX
-51,529
Closed -$2.42M
TAP icon
3938
Molson Coors Class B
TAP
$7.68B
-130,959
Closed -$6.3M
TATT icon
3939
TAT Technologies
TATT
$543M
-7,766
Closed -$237K
TBI
3940
Trueblue
TBI
$234M
-31,426
Closed -$204K
TCOM icon
3941
CALL
Trip.com Group
TCOM
$27.5B
-200
Closed -$11.7K
TDG icon
3942
TransDigm Group
TDG
$69.2B
-22,172
Closed -$31.7M
TDOC icon
3943
Teladoc Health
TDOC
$1.58B
-63,424
Closed -$552K
TDY icon
3944
Teledyne Technologies
TDY
$30.4B
-12,584
Closed -$6.45M
TECS icon
3945
Direxion Daily Technology Bear 3x ETF
TECS
$78.2M
-50
Closed -$13.4K
TER icon
3946
Teradyne
TER
$54.8B
-914,653
Closed -$99.9M
TFSL icon
3947
TFS Financial
TFSL
$5.1B
-26,201
Closed -$339K
TGI
3948
DELISTED
Triumph Group
TGI
-951,595
Closed -$24.5M
TGS icon
3949
Transportadora de Gas del Sur
TGS
$4.59B
-19,054
Closed -$493K
THD icon
3950
iShares MSCI Thailand ETF
THD
$361M
-585
Closed -$29.5K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2025 Portfolio in Review

As of Q3 2025, Qube Research & Technologies (QRT) held 4,043 positions worth $96.8B, down 1.7% from $98.4B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Qube Research & Technologies (QRT) withdrew a net $6.28B in Q3 2025, closing 517 positions and reducing 1,501 holdings. Its most notable exit was Applovin, an estimated $390M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Qube Research & Technologies (QRT) opened a new position in Broadcom worth $754M.

  • Qube Research & Technologies (QRT)'s largest Q3 2025 buy was Broadcom: 2,284,316 shares worth $754M.
  • Qube Research & Technologies (QRT) added most to Microsoft in Q3 2025, an estimated $775M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $735M.
  • Qube Research & Technologies (QRT) fully exited Applovin in Q3 2025, selling an estimated $390M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.4% of its $96.8B portfolio in Q3 2025.
  • Qube Research & Technologies (QRT) opened 538 new positions and closed 517 in Q3 2025.
  • Qube Research & Technologies (QRT)'s portfolio value fell 1.7% quarter-over-quarter to $96.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.